Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL.

Annals of hematology - 1 Dec 2024

Mijiti Mutibaier, Wang Chun, Tian Wenxin, Shi Qiping, Zhang Fang, Abulaiti Renaguli, Qi Xiaolong, Kou Zhen, Liu Cuicui, Wang Zengsheng, Zhai Shunsheng, An Li, Huang Qin, Shao Yang, Wufuer Guzailinuer, Li Yan

Abstract excerpt

Diffuse large B-cell lymphoma (DLBCL) demonstrates significant heterogeneity, investigations into the distinctions in clinical and molecular characteristics between Chinese Uygur and Han DLBCL patients remain unexplored. We retrospectively reviewed 279 DLBCL patients (105 Uygur and 174 Han patients), of which 155 patients underwent genetic profiling by NGS. Compared with Han patient, Uygur patients have better...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Incidence

Share to Lymphoma, Large B-Cell, Diffuse

Share to Prognosis

Share to Recurrence

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 39187692
DOI: 10.1007/s00277-024-05961-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL.PMID 39187692Read ↗

TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosisSemantic proximity Read ↗

Integrating genomic features for prognosis in Chinese patients with diffuse large B-cell lymphoma following R-CHOP therapy.Semantic proximity Read ↗

TP53 mutation predict poor prognosis in diffuse large B-cell lymphoma: a single-center study.Semantic proximity Read ↗

TP53 mutations predict poor prognosis in diffuse large B-cell lymphoma: A single-center studySemantic proximity Read ↗

Comprehensive Analysis of TP53 Mutation Characteristics and Identification of Patients with Inferior Prognosis and Enhanced Immune Escape in Diffuse Large B Cell LymphomaSemantic proximity Read ↗

Prognostic Impact of TP53 Mutations in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Prognostic impact of TP53 mutations in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Distinct subtype distribution and somatic mutation spectrum of lymphomas in East Asia.Semantic proximity Read ↗

Characteristics and prognosis of rrDLBCL with TP53 mutations and a high-risk subgroup represented by the co-mutations of DDX3X-TP53.Semantic proximity Read ↗

Genomic Landscape and Molecular Subtypes of Primary Central Nervous System LymphomaSemantic proximity Read ↗

Optimized interpretation of p53 immunohistochemistry for prediction of TP53 mutations and patient survival in DLBCL.Semantic proximity Read ↗

Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.